- Home
- GDYN vs PRME Comparison
GDYN vs PRME Comparison
Compare GDYN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | PRME |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 616.1M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GDYN | PRME |
|---|---|---|
| Price | $7.15 | $3.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $11.25 | $6.42 |
| AVG Volume (30 Days) | 1.1M | ★ 3.3M |
| Earning Date | 03-05-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 457.52 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $405,955,000.00 | $5,977,000.00 |
| Revenue This Year | $19.77 | $95.64 |
| Revenue Next Year | $10.12 | N/A |
| P/E Ratio | $43.70 | ★ N/A |
| Revenue Growth | 23.63 | ★ 647.13 |
| 52 Week Low | $6.94 | $1.11 |
| 52 Week High | $25.50 | $6.94 |
Technical Indicators
Market Signals| Indicator | GDYN | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 26.05 | 40.32 |
| Support Level | $6.94 | $3.21 |
| Resistance Level | $8.51 | $4.21 |
| Average True Range (ATR) | 0.39 | 0.34 |
| MACD | -0.18 | -0.10 |
| Stochastic Oscillator | 7.64 | 12.17 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.